Abstract
PurposeBecause of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have